Surmodics | SRDX - Debt


Surmodics reported $29.55M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Align Technology USD 121.27M 1.75M Sep/2025
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 366.28M 13.25M Sep/2025
Artivion USD 317.78M 619K Dec/2024
Baxter International USD 9.71B 13M Sep/2025
Boston Scientific USD 12.05B 19M Sep/2025
EDAP TMS EUR 7.55M 1.41M Sep/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Haemonetics USD 1.22B 54K Sep/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
J&J USD 45.8B 4.97B Sep/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Nektar Therapeutics USD 0 0 Jun/2022
Option Care Health USD 1.15B 1M Dec/2025
Stryker USD 14.86B 1.74B Dec/2025
Surmodics USD 29.55M 111K Sep/2024
Trinity Biotech USD 100.76M 7.05M Dec/2024